Harvard Bioscience
HBIO
#8966
Rank
NZ$0.16 B
Marketcap
$3.73
Share price
0.48%
Change (1 day)
-55.52%
Change (1 year)

Harvard Bioscience (HBIO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$0.11 Billion

According to Harvard Bioscience's latest financial reports the company's total liabilities are NZ$0.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Harvard Bioscience - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$0.10 B-11.75%
2022-12-31NZ$0.11 B-0.33%
2021-12-31NZ$0.11 B4.8%
2020-12-31NZ$0.11 B-10.7%
2019-12-31NZ$0.12 B-3.55%
2018-12-31NZ$0.12 B219.6%
2017-12-31NZ$40.06 M-21.98%
2016-12-31NZ$51.34 M-17.21%
2015-12-31NZ$62.02 M20.15%
2014-12-31NZ$51.62 M3.53%
2013-12-31NZ$49.86 M40.13%
2012-12-31NZ$35.58 M-10.81%
2011-12-31NZ$39.89 M-10.92%
2010-12-31NZ$44.78 M1.73%
2009-12-31NZ$44.02 M75.54%
2008-12-31NZ$25.07 M-22.28%
2007-12-31NZ$32.26 M6.5%
2006-12-31NZ$30.29 M-10.81%
2005-12-31NZ$33.97 M-31.76%
2004-12-31NZ$49.78 M9.52%
2003-12-31NZ$45.45 M23.89%
2002-12-31NZ$36.69 M-2.02%
2001-12-31NZ$37.44 M